Featured Insight

Global Financial and Economic Crime Outlook 2025

April 10, 2025

Latest Insights

Events

Securities Enforcement Forum Central 2025

September 25, 2025

On September 25, John Rademacher will be joining a distinguished panel at Securities Enforcement Forum Central 2025, where leading voices in securities enforcement will address the growing complexity of multi-agency investigations.

DRBF 2nd Annual Latin American Conference

September 10, 2025 – September 12, 2025

Secretariat is proud to sponsor the Dispute Resolution Board Foundation (DRBF) 2nd Annual Latin American Conference, taking place 10–12 September in Buenos Aires, Argentina.

featured Engagements

Biopharmaceutical Reasonable Royalties on Trial

When our client, a biopharmaceutical company, had exclusively licensed a patent for a novel type of cancer immunotherapy, a competitor undertook substantial efforts to be first to market for its lead indication despite being aware of potential infringement claims against its therapy. Upon the competitor achieving FDA approval, our client filed patent infringement claims. After an eight-day trial, the jury returned a verdict in favor of our client with a damages award that precisely matched the trial testimony.

Media Contact

If you would like to schedule an interview or would like more information about our firm and individual experts, please contact:

Nathan Jenks
Director of Marketing & Communications
Email: njenks@secretariat-intl.com